Jefferies Starts PROLOR Biotech (PBTH) at Buy; Long-Acting Growth Story
Tweet Send to a Friend
Jefferies initiates coverage on PROLOR Biotech (NYSE: PBTH) with a Buy. PT $8.00.
Analyst, Biren Amin, said, "PBTH’s strategy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Biren Amin, said, "PBTH’s strategy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
